本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2021/10/61 分钟阅读
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Withdrawal
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing the notice that published in the Federal Register of September 30, 2021, that announced the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Register notice was published in error and is being withdrawn.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →